MAPT and neurodegenerative disease: Distinct localization of tau-deposits compared to that found in another neurodegenerative diseases, e.g. Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS), could indicate that anti-IgLON5 is a novel tauopathy (17).